12: Talking Tumors: Adaptive Approaches in Triple-Negative and HR-Positive Breast Cancers

40:01
 
Share
 

Manage episode 244506937 series 2395115
By Audioboom and OncLive® On Air. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
Jane L. Meisel, MD, and Aditya Bardia, MD, MPH, shed light on treatment considerations for women with triple-negative breast cancer (TNBC) who are candidates for neoadjuvant therapy, emerging treatment strategies for patients with metastatic TNBC, as well as the optimal timing of genomic testing in women with progressive hormone receptor–positive disease.

66 episodes